Skip to content

About us
Products
Business development
Content Hub
Contact us

General marketing opt-in

Which products are you interested in hearing about?

Fencino (fentanyl)Zeyzelf (rivastigmine)Seroquel (quetiapine)All

I consent to having Luye Pharma store my submitted information so they can send me marketing material.

By clicking below to submit this form, you acknowledge that the information you provide will be processed in accordance with our Privacy Policy.

You can opt out/unsubscribe at any time by clicking here.

To find out more about business opportunities and partnerships, get in touch.

Get in touch

UK-COR-26 February 2024

European offices

United Kingdom | Germany | Switzerland

Luye UK
Luye Pharma Ltd
Surrey Technology Centre
Guildford
Surrey GU2 7YG

Luye Germany
Am Windfeld 35,
83714 Miesbach
Germany

Luye Pharma Switzerland AG
Baeumleingasse 22
4051 Basel
Switzerland

Other links

Luye Life Sciences
Luye Pharma Europe
Luye Pharma Group

UK-COR-24a(1) April 2024

This page is intended for a UK healthcare professional audience and other relevant decision makers only

About us
Products
Business development
Media Hub
Contact us

Policies & Plans
Marketing opt-in

Professional access

To access this information you must confirm that you are a healthcare professional.

I am a healthcare professional I am a member of the public

You are leaving the site

You are now leaving the Luye Pharma Ltd website to go to an external website over which Luye Pharma has no control and to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website. Click OK to proceed.

OK Stay on site

You are leaving the site

You are now leaving the Luye Pharma Ltd website to go to an external website over which Luye Pharma has no control and to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website. Click OK to proceed.

OK Stay on site

You are leaving the site

You are now leaving the Luye Pharma Ltd website to go to an external website over which Luye Pharma has no control and to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website. Click OK to proceed.

OK Stay on site

Media access

This page is intended for media, journalists and investors.

Are you a member of the media, a journalist or investor?

UK-COR-44 April 2024

Professional access

To access this information you must confirm that you are a healthcare professional.

I am a UK healthcare professional I am a member of the UK public

UK-COR-23(1) April 2024